Harmonicare Medical : APPOINTMENT OF EXECUTIVE DIRECTORS, CHIEF EXECUTIVE OFFICER, CHIEF FINANCIAL OFFICER AND VICE PRESIDENTS

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1509)

APPOINTMENT OF EXECUTIVE DIRECTORS, CHIEF EXECUTIVE OFFICER, CHIEF FINANCIAL OFFICER AND VICE PRESIDENTS

The board of directors (the "Board") of Harmonicare Medical Holdings Limited (the "Company", together with its subsidiaries, the "Group") is pleased to announce that the following appointments will take effect from 11 August 2020:

1. Mr. Yang Guo ("Mr. Yang") was appointed as an executive director and the chief executive officer of the Company;
2. Mr. Wei Rongda ("Mr. Wei") was appointed as an executive director and a vice president of the Company; and
3. Mr. Chen Longzhen ("Mr. Chen") was appointed as the chief financial officer and a vice president of the Company.

The biographical details of Mr. Yang, Mr. Wei and Mr. Chen are set out below:

Mr. Yang Guo

Mr. Yang Guo (楊國), aged 37, has more than 15 years of working experience. Mr. Yang worked as a vice president and chief executive officer responsible for strategy formulation and operation management of Beijing Century Yaolan Network Technology Co., Ltd. (北京世紀搖籃網絡技術 有限公司) successively. Then he served as a vice president responsible for assisting the chairman of the group in participating in post-investment management and innovative integration of group cluster companies of Shanghai Tianyi Investment (Group) Co., Ltd. (上海天億投資（集團）有限 公司) and acted as a chief executive officer responsible for strategy formulation and operation management of Chengdu Tiandiwang Information Technology Co., Ltd. (成都天地網信息科技 有限公司), which was held by Shanghai Tianyi Investment (Group) Co., Ltd. (上海天億投資（集 團）有限公司). Mr. Yang graduated from Jilin University (吉林大學) with a bachelor's degree in engineering and from China Europe International Business School (中歐國際工商學院) with a master's degree in business administration.

Mr. Yang was a director of Bencao Zhenxuan (Chengdu) Network Technology Co., Ltd. (本草珍選 （成都）網絡科技有限公司), a company established in the People's Republic of China and engaged in the internet business, which was deregistered in June 2020 due to voluntary cessation of its

business. Mr. Yang confirmed that the company was solvent at the time of it being deregistered and there was no wrongful act on his part leading to such deregistration and he is not aware of any actual or potential claim that has been or will be made against him as a result of the deregistration, and that his involvement in the above company was part and parcel of his services as a director of such company and that no misconduct or misfeasance had been involved in the deregistration of such company.

1

Mr. Yang has entered into a service contract as an executive director with the Company for a term of three years from 11 August 2020, which may be terminated by either party by giving one-month written notice. He shall be subject to retirement by rotation and re-election at the annual general meetings of the Company in accordance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the articles of association of the Company. Pursuant to the terms of appointment as recommended by the remuneration committee of the Board, Mr. Yang is entitled to receive a salary of RMB100,000 per month and discretionary bonus, which are determined by the Board with reference to his duties and responsibilities in the Company, the results of the Company, the prevailing market condition and his performance.

Mr. Wei Rongda

Mr. Wei Rongda (魏榮達), aged 37, is currently the general manager of the operation management department of the Group. Mr. Wei joined Shanxi Modern Woman Hospital (山西現代婦產醫院) in March 2005 and was the general manager of Weihai Modern Woman Hospital (威海現代婦產

醫院) from April 2008 to December 2012. Mr. Wei acted as the general manager of Heilongjiang HarMoniCare Hospital (黑龍江和美婦產醫院), a subsidary of the Group from December 2012

to July 2020, and a district general manager of the Group who was in charge of the operation management of Heilongjiang HarMoniCare Hospital (黑龍江和美婦產醫院), Wuhan Modern Hospital (武漢現代醫院) and Wuxi HarMoniCare Hospital (無錫和美醫院) from September 2018

to July 2020, and began to serve as the general manager of the operation management department of the Group from July 2020. Mr. Wei holds a master's degree in project management from China University of Geosciences (中國地質大學).

Mr. Wei has entered into a service contract as an executive director with the Company for a term of three years from 11 August 2020, which may be terminated by either party by giving one-month written notice. He shall be subject to retirement by rotation and re-election at the annual general meetings of the Company in accordance with the Listing Rules and the articles of association of the Company. Pursuant to the terms of appointment as recommended by the remuneration committee of the Board, Mr. Wei is entitled to receive a salary of RMB50,000 per month and discretionary bonus, which are determined by the Board with reference to his duties and responsibilities in the Company, the results of the Company, the prevailing market condition and his performance.

As at the date of this announcement, Mr. Wei is deemed to be interested in 758,000 shares of the Company directly held by Ms. Zhang Jinghua (張敬華), the spouse of Mr. Wei. Ms. Zhang Jinghua is also the sister of Ms. Zhang Qinghua (張慶華), who is the spouse of Mr. Lin Yuming (the chairman, an executive director and president of the Company).

Mr. Chen Longzhen

Mr. Chen Longzhen (陳隆禎), aged 63, is currently the acting chief financial officer of the Group.

Mr. Chen served as the finance manager of Shandong Huimin Huarun Textile Co., Ltd. (山東惠 民華潤紡織有限公司) from December 1999 to October 2001. Mr. Chen successively served as

an assistant of general manager and finance director of China Resources Jinhua Co., Ltd. (華潤 錦華股份有限公司) (currently known as Skyworth Digital Co., Ltd. (創維數字股份有限公司),

listed on the Shenzhen Stock Exchange (stock code: 000810)) from October 2001 to February 2004. Mr. Chen served as a finance director of Shandong Juli Co., Ltd. (山東巨力股份有限公 司) (currently known as Weichai Heavy Machinery Co., Ltd. (濰柴重機股份有限公司), listed

2

on the Shenzhen Stock Exchange (stock code: 000880)) from March 2004 to August 2005. Mr. Chen served as a finance director of Gaode Zhongcai Technology Co., Ltd. (高德中彩科技有限

公司) from August 2006 to March 2008, and a finance director of Xiamen Tianwei Industrial Co., Ltd. (廈門天威實業有限公司) from March 2008 to May 2010. Mr. Chen served as a vice finance

director and vice director in securities investment department of Bosheng Medical Investment Co., Ltd.（博生醫療投資股份有限公司）from June 2010 to February 2015, mainly responsible for

management of finance, securities and investment. Mr. Chen served as the chief financial officer of the Group from March 2015 to August 2017, mainly responsible for general finance management of the Group. Mr. Chen has been acting as the acting chief financial officer of the Group since

December 2019. Mr. Chen obtained an associate degree in industry accounting from Shandong TV University (山東廣播電視大學) in July 1986, and studied in economics management at Shandong Cadres Correspondence University (山東幹部函授大學) from July 1994 to June 1997. Mr. Chen

also obtained the qualification of senior accountant from Human Resources and Social Security Department of Shandong Province (山東省人力資源和社會保障廳) in November 1997.

Save as disclosed above, as at the date of this announcement, (i) Mr. Yang, Mr. Wei and Mr. Chen do not hold any other positions with the Company or other members of the Group; (ii) they do not have any relationships with any directors, senior management, substantial shareholders or controlling shareholders of the Company; (iii) they do not hold any directorships in other public companies, the securities of which are listed on any securities market in Hong Kong or overseas at present or in the last three years; and (iv) they do not have any interests in the shares or underlying shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Save as disclosed above, there is no other information that is required to be disclosed in accordance with Rules 13.51(2)(h) to 13.51(2)(v) of the Listing Rules and there is no other matter in relation to the appointments of Mr. Yang, Mr. Wei and Mr. Chen that ought to be brought to the attention of the shareholders of the Company.

The Board would like to extend a warm welcome to Mr. Yang, Mr. Wei and Mr. Chen on their appointments.

By Order of the Board

Harmonicare Medical Holdings Limited

Lin Yuming

Chairman, Executive Director and President

Hong Kong, 11 August 2020

As at the date of this announcement, the executive directors of the Company are Mr. Lin Yuming, Mr. Yang Guo and Mr. Wei Rongda; the non-executive directors of the Company are Mr. Lin Yuguo, Mr. Qiu Jianwei and Mr. Xu Jun; and the independent non-executive directors of the Company are Mr. Kong Aiguo, Ms. Fang Lan and Mr. Cai Jiangnan.

3